Akebia Therapeutics Inc.

NASDAQ: AKBA · Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT

Akebia Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.77 -4.48 -0.99 -1.53
PEG Ratio
-0.32 0.09 0.02 0.04
PS Ratio
2.50 1.19 0.36 1.76
PB Ratio
-8.15 -7.6 11.29 4.91
P/FCF Ratio
-9.85 -9.94 -1.44 -1.48
P/OCF Ratio
-9.86 -9.94 -1.44 -1.48
OCF/S Ratio
-0.25 -0.12 -0.25 -1.18
Debt / Equity Ratio
-0.97 -3.41 10.68 1.78
Quick Ratio
1.21 1.03 1.31 0.91
Current Ratio
1.41 1.18 1.48 1.06
Asset Turnover
0.73 0.81 0.83 0.41
Interest Coverage
-2.78 -7.67 -4.03 -13.31
Return on Equity
1.41 1.70 -11.35 -3.2
Return on Assets
-0.31 -0.21 -0.3 -0.47
Return on Invested Capital
-0.35 -0.28 -0.27 -0.62
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.61 0.62 0.71 0.28
Net Profit Margin
-0.43 -0.27 -0.36 -1.15
Pretax Profit Margin
-0.43 -0.27 -0.32 -1.32
Operating Profit Margin
-0.32 -0.24 -0.22 -1.24
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.09 -0.04 -0.15 -1.06